×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MASI – masimo corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MASI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
10:19 am
masi
Masimo Co. (NASDAQ: MASI) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $190.00 price target on the stock, up previously from $170.00.
Low
Report
Masimo Co. (NASDAQ: MASI) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $190.00 price target on the stock, up previously from $170.00.
11/20
05:53 pm
masi
Automotive Audio Speakers Market to Grow by USD 9.02 Billion (2024-2028) as AI Powers Market Evolution, Cost-Effective Aftermarket Speakers Boost Revenue - Technavio [Yahoo! Finance]
Low
Report
Automotive Audio Speakers Market to Grow by USD 9.02 Billion (2024-2028) as AI Powers Market Evolution, Cost-Effective Aftermarket Speakers Boost Revenue - Technavio [Yahoo! Finance]
11/14
09:00 am
masi
Masimo to Present in the Jefferies London Healthcare Conference
Low
Report
Masimo to Present in the Jefferies London Healthcare Conference
11/13
09:00 am
masi
Masimo to Present in Stifel 2024 Healthcare Conference
Low
Report
Masimo to Present in Stifel 2024 Healthcare Conference
11/7
05:37 am
masi
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation? [Yahoo! Finance]
Medium
Report
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation? [Yahoo! Finance]
11/6
03:25 pm
masi
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth [Yahoo! Finance]
Low
Report
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth [Yahoo! Finance]
11/6
11:05 am
masi
Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at Wells Fargo & Company from $160.00 to $171.00. They now have an "overweight" rating on the stock.
Medium
Report
Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at Wells Fargo & Company from $160.00 to $171.00. They now have an "overweight" rating on the stock.
11/6
10:15 am
masi
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands [Yahoo! Finance]
Medium
Report
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:31 pm
masi
Form 8-K MASIMO CORP For: Nov 13
Low
Report
Form 8-K MASIMO CORP For: Nov 13
11/18
09:02 am
masi
Form 8-K MASIMO CORP For: Nov 13
Low
Report
Form 8-K MASIMO CORP For: Nov 13
11/15
06:05 pm
masi
Form 4 MASIMO CORP For: Nov 13 Filed by: Levy Tao
Low
Report
Form 4 MASIMO CORP For: Nov 13 Filed by: Levy Tao
11/13
05:03 pm
masi
Form 4 MASIMO CORP For: Nov 11 Filed by: Brennan Michelle
Low
Report
Form 4 MASIMO CORP For: Nov 11 Filed by: Brennan Michelle
11/6
06:02 am
masi
Form 10-Q MASIMO CORP For: Sep 28
Medium
Report
Form 10-Q MASIMO CORP For: Sep 28
11/5
04:08 pm
masi
Form 8-K MASIMO CORP For: Nov 05
High
Report
Form 8-K MASIMO CORP For: Nov 05
10/29
05:00 pm
masi
Form 8-K MASIMO CORP For: Oct 24
Low
Report
Form 8-K MASIMO CORP For: Oct 24
10/18
09:08 am
masi
Form 4 MASIMO CORP For: Oct 16 Filed by: Scannell Timothy J
Low
Report
Form 4 MASIMO CORP For: Oct 16 Filed by: Scannell Timothy J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/2
Masimo Announces FDA Clearance of Continuous RRp® Monitoring
9.0%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic 4.2%
3/12 Form 4 MASIMO CORP For: Mar 10 Filed by: KIANI JOE E 4.1%
8/6 Masimo Co. (NASDAQ: MASI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.8%
4/24 Form 4 MASIMO CORP For: Apr 22 Filed by: KIANI JOE E 3.0%
6/7 Form 4 MASIMO CORP For: Jun 05 Filed by: Muhsin Bilal 3.0%
8/14 Form 4 MASIMO CORP For: Aug 12 Filed by: Lee Yongsam 3.0%
5/16 Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution 3.0%
6/3 Form 4 MASIMO CORP For: May 30 Filed by: Cohen H Michael 2.6%
1/17 Form 4 MASIMO CORP For: Jan 16 Filed by: Young Micah W 2.3%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic 4.2%
3/12 Form 4 MASIMO CORP For: Mar 10 Filed by: KIANI JOE E 4.1%
8/6 Masimo Co. (NASDAQ: MASI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.8%
4/24 Form 4 MASIMO CORP For: Apr 22 Filed by: KIANI JOE E 3.0%
6/7 Form 4 MASIMO CORP For: Jun 05 Filed by: Muhsin Bilal 3.0%
8/14 Form 4 MASIMO CORP For: Aug 12 Filed by: Lee Yongsam 3.0%
5/16 Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution 3.0%
6/3 Form 4 MASIMO CORP For: May 30 Filed by: Cohen H Michael 2.6%
1/17 Form 4 MASIMO CORP For: Jan 16 Filed by: Young Micah W 2.3%
TOP News Decliners
5/6
Q1/2019 3/30/2019 EPS 0.790 ZacksConsensus 0.750 ActVsEst 0.040 - Beat
-6.9%
3/19 Masimo Announces Agreement to Acquire TNI medical AG -5.5%
4/28 Masimo Corp (MASI) CEO Joe Kiani on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
9/9 Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® -5.3%
10/30 Form 10-Q MASIMO CORP For: Sep 28 -4.2%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic -4.1%
4/16 Masimo and Samsung Partner to Package Masimo SafetyNet™ with Select Samsung Phones to Speed COVID-19 Response Efforts -3.7%
8/2 Form 4 MASIMO CORP For: Jul 31 Filed by: KIANI JOE E -3.3%
7/31 Form 8-K MASIMO CORP For: Jul 31 -3.2%
2/20 Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at UBS Group AG from $190.00 to $207.00. They now have a "buy" rating on the stock. -2.8%
3/19 Masimo Announces Agreement to Acquire TNI medical AG -5.5%
4/28 Masimo Corp (MASI) CEO Joe Kiani on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
9/9 Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® -5.3%
10/30 Form 10-Q MASIMO CORP For: Sep 28 -4.2%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic -4.1%
4/16 Masimo and Samsung Partner to Package Masimo SafetyNet™ with Select Samsung Phones to Speed COVID-19 Response Efforts -3.7%
8/2 Form 4 MASIMO CORP For: Jul 31 Filed by: KIANI JOE E -3.3%
7/31 Form 8-K MASIMO CORP For: Jul 31 -3.2%
2/20 Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at UBS Group AG from $190.00 to $207.00. They now have a "buy" rating on the stock. -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: